Oophorectomy
Breast and ovarian cancer risks
Chemoprevention and breast cancer
Chemoprevention and ovarian cancer
Close surveillance for breast cancer
Close surveillance for ovarian cancer
Oophorectomy
Primary
Fallopian Tube Malignancies in BRCA-Positive Women Undergoing Surgery for
Ovarian Cancer Risk Reduction
Michael J. Callahan, Christopher P. Crum,
Fabiola Medeiros, David W. Kindelberger, Julia A. Elvin, Judy E. Garber,
Colleen M. Feltmate, Ross S. Berkowitz, Michael G. Muto. Journal
of Clinical Oncology. Volume 25, No. 25: p. 3985-3990, September 2007.
Effect
of Short-Term Hormone Replacement Therapy on Breast Cancer Risk Reduction
After Bilateral Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers:
The PROSE Study Group
Timothy R. Rebbeck, Tara Friebel, Theresa Wagner,
Henry T. Lynch, Judy E. Garber, Mary B. Daly, Claudine Isaacs, Olufunmilayo
I. Olopade, Susan L. Neuhausen, Laura van 't Veer, Rosalind Eeles , D.
Gareth Evans, Gail Tomlinson, Ellen Matloff, Steven A. Narod, Andrea Eisen,
Susan Domchek, Katrina Armstrong, and Barbara L. Weber. Journal
of Clinical Oncology, (Published on-line ahead of print).,October 2005.
The
effect of total hysterectomy on specific sexual sensations
Martha
F. Goetsch. American Journal of Obstetrics
and Gynecology, Volume
196, Issue 6: p. 1922-1927, June 2005.
Four
year follow-up of outcomes following risk-reducing salpingo-oophorectomy
in BRCA mutation carriers
Y. Kemel, N. D. Kauff, M. E. Robson, D. J.
Goldfrank, E. Wadsworth, T. Diiorio, J. Boyd, C. A. Hudis, R. R. Barakat,
K. Offit. American Society of Clinical Oncologists. (abstract # 1013),
May 2005. (Annual conference proceedings abstract)
Risk-reducing salpingo-oophorectomy
in BRCA mutation carriers: Role of serial sectioning in the detection of
occult malignancy
C. Bethan Powell, Eric Kenley, Lee-may Chen, Beth
Crawford, Jane McLennan, Charles Zaloudek, Miriam Komaromy, Mary Beattie,
John Ziegler. Journal of Clinical Oncology, Volume 23, Number 1:p. 127-132,
January 2005.
BRCA
germline mutations in Jewish women with uterine serous papillary carcinoma
Ofer
Lavie, Gila Hornreich, Alon Ben-Arie, Gad Rennert, Yoram Cohen, Rehuven
Keidar, Shlomi Sagi, Efrat Levy Lahad, Ron Auslander and Uzi Beller. Gynecologic
Oncology, Volume 92, Number 2: p. 521-524, February 2004.
Genetic
testing for a BRCA1 mutation: Prophylactic surgery and screening behavior
in women 2 years post testing
Jeffrey R. Botkin, Ken R. Smith, Robert
T. Croyle, Bonnie J. Baty, Jean E. Wylie, Debra Dutson, Anna Chan, Heidi
A. Hamann, Caryn Lerman, Jamie McDonald, Vickie Venne, John H. Ward, Elaine
Lyon. American Journal of Medical Genetics. Volume 118A, Issue 3: p. 201-209,
February 2003.
Effect of prevention
strategies on survival and quality-adjusted survival of women with BRCA1/2
mutations: An updated decision analysis
Victor R. Grann, Judith S.
Jacobson, Dustin Thomason, Dawn Hershman, Daniel F. Heitjan, Alfred I.
Neugut. Journal of Clinical Oncology. Volume 20, Issue 10: p. 2520-2529,
May 2002.
Effect of prevention
strategies on survival and quality-adjusted survival of women with BRCA1/2
mutations: An updated decision analysis
Victor R. Grann, Judith S.
Jacobson, Dustin Thomason, Dawn Hershman, Daniel F. Heitjan, Alfred I.
Neugut. Journal of Clinical Oncology. Volume 20, Issue 10: p. 2520-2529,
May 2002.
Risk-reducing
salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation
Noah
D. Kauff, M.D., Jaya M. Satagopan, Ph.D., Mark E. Robson, M.D., Lauren
Scheuer, M.S., Martee Hensley, M.D., Clifford A. Hudis, M.D., Nathan A.
Ellis, Ph.D., Jeff Boyd, Ph.D., Patrick I. Borgen, M.D., Richard R. Barakat,
M.D., Larry Norton, M.D., Mercedes Castiel, M.D., Khedoudja Nafa, Ph.D.,
and Kenneth Offit, M.D., M.P.H. New England
Journal of Medicine. Volume
346: p. 1609-1615, May 2002.
Prophylactic
oophorectomy in carriers of BRCA1 or BRCA2 mutations
Timothy R. Rebbeck,
Ph.D., Henry T. Lynch, M.D., Susan L. Neuhausen, Ph.D., Steven A. Narod,
M.D., Laura van't Veer, Ph.D., Judy E. Garber, M.D., M.P.H., Gareth Evans,
M.D., Claudine Isaacs, M.D., Mary B. Daly, M.D., Ph.D., Ellen Matloff,
M.S., Olufunmilayo I. Olopade, M.D., Barbara L. Weber, M.D. New
England Journal of Medicine. Volume 346: p. 1616-1622, May 2002. (Note: a
review of the above two articles on oophorectomy and breast and ovarian
cancer risk appears in the same issue of the New England Journal of Medicine.)
Outcome of preventive
surgery and screening for breast and ovarian cancer in BRCA mutation carriers
Lauren
Scheuer, Noah Kauff, Mark Robson, Bridget Kelly, Richard Barakat, Jaya
Satagopan, Nathan Ellis, Martee Hensley, Jeff Boyd, Patrick Borgen, Larry
Norton, Kenneth Offit. Journal of Clinical Oncology. Volume 20, Issue 5:
p. 1260-1268, March 2002.
Natural hormone replacement
therapy: What it is and what consumers really want
Dana Reed-Kane,
PharmD, FIACP, FACA. International Journal of
Pharmaceutical Compounding.
Volume 5, Number 5: p. 332-335. September/October 2001.
Tubal
ligation and risk of ovarian cancer in carriers of Brca1 or BRCA2 mutations:
A case-control study
Steven A Narod, Ping Sun, Parviz Ghadirian, Henry
Lynch, Claudine Isaacs, Judy Garber, Barbara Weber, Beth Karlan, David
Fishman, Barry Rosen, Nadine Tung, Susan L Neuhausen. Lancet. Volume 12,
Issue 357(9267): p. 1467-70, May 2001.